Behavioural and microglial effect of cannabinoids in neuropathic pain

dc.contributor.advisorTrang, Tuan
dc.contributor.authorDavidson, ChloƩ E. D.
dc.contributor.committeememberBorgland, Stephanie
dc.contributor.committeememberHill, Matthew
dc.date2022-11
dc.date.accessioned2022-09-20T16:11:51Z
dc.date.available2022-09-20T16:11:51Z
dc.date.issued2022-09
dc.description.abstractChronic pain is a disease affecting 1 in 5 Canadians and the leading cause of disability worldwide. Among the most debilitating forms of chronic pain is neuropathic pain, which is caused by injury or disease of the nervous system. Neuropathic pain is difficult to manage clinically because it is often resistant to strong analgesics including opioids. Since therapeutic options are limited, some patients resort to medical cannabis to alleviate pain symptoms. Pain is the most common medical reason to use cannabis and cannabinoids. However, the efficacy of cannabis for pain, as well as its potential health impacts, are not well defined. My project addresses this knowledge gap by characterizing the behavioural and cellular effects of cannabis in the rat spared nerve injury (SNI) model. This neuropathic pain model replicates the mechanical pain sensitivity reported in neuropathic pain patients, including mechanical allodynia, which is an abnormal sensitivity to tactile stimuli in which even light touch can elicit pain. Prior research shows that microglia, the resident immune cells of the central nervous system, play a central role in the development of chronic neuropathic pain after peripheral nerve injury in males. In this study, we assessed the effects of vaporized whole cannabis extract and a combination of THC and CBD on mechanical hypersensitivity in spared nerve injury (SNI) male and female Sprague-Dawley rats. I also investigated the effect of cannabinoid exposure on spinal microglia. I find that cannabis and cannabinoid extracts transiently reversed mechanical allodynia in the spared nerve injury model of neuropathic pain in a sex- and compound-dependent manner. Additionally, I demonstrate a compound-dependent effect of cannabinoids on microglial reactivity.en_US
dc.identifier.citationDavidson, C. E. D. (2022). Behavioural and microglial effect of cannabinoids in neuropathic pain (Master's thesis, University of Calgary, Calgary, Canada). Retrieved from https://prism.ucalgary.ca.en_US
dc.identifier.urihttp://hdl.handle.net/1880/115246
dc.identifier.urihttps://dx.doi.org/10.11575/PRISM/40258
dc.language.isoengen_US
dc.publisher.facultyCumming School of Medicineen_US
dc.publisher.institutionUniversity of Calgaryen
dc.rightsUniversity of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission.en_US
dc.subjectPainen_US
dc.subjectChronic Painen_US
dc.subjectNeuropathic Painen_US
dc.subjectCannabisen_US
dc.subjectCannabinoidsen_US
dc.subject.classificationNeuroscienceen_US
dc.titleBehavioural and microglial effect of cannabinoids in neuropathic painen_US
dc.typemaster thesisen_US
thesis.degree.disciplineMedicine ā€“ Neuroscienceen_US
thesis.degree.grantorUniversity of Calgaryen_US
thesis.degree.nameMaster of Science (MSc)en_US
ucalgary.item.requestcopyfalseen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ucalgary_2022_davidson_chloe.pdf
Size:
2.36 MB
Format:
Adobe Portable Document Format
Description:
Master's Thesis
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.62 KB
Format:
Item-specific license agreed upon to submission
Description: